Skip to content
Home/Companies/Biotech/BlueRock Therapeutics
BT

BlueRock Therapeutics

Biotech·United States·Exited 2019·Held 3yr

BlueRock Therapeutics is a biotech company, headquartered in United States.

Entry
2016
Hold
3yr
Exit
2019
Est. EV
–

Who owns BlueRock Therapeutics?

BlueRock Therapeutics was owned by Leaps by Bayer through Leaps by Bayer (2015 vintage) from 2016 to 2019, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

Leaps by Bayer
Investor
Leaps by Bayer
Leaps by Bayer · 2015 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019

More from Leaps by Bayer

Other portfolio companies in the same fund.

Celea Therapeutics
Active
BiotechUnited States· 2026
Leaf Agriculture
Active
ClimateTechUnited States· 2026
SonoThera
Active
BiotechUnited States· 2026
Souffle Therapeutics
Active
BiotechUnited States· 2025
WellTheory
Active
HealthTechUnited States· 2025
Boundless Bio
Exited 2024
BiotechUnited States· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings